254 related articles for article (PubMed ID: 31440815)
1. Clinical characteristics of acinic cell carcinoma and secretory carcinoma of the parotid gland.
Terada T; Kawata R; Noro K; Higashino M; Nishikawa S; Haginomori SI; Kurisu Y; Kuwabara H; Hirose Y
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3461-3466. PubMed ID: 31440815
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of immunohistochemistry to distinguish between secretory carcinoma and acinic cell carcinoma in the salivary gland.
Hamamoto Y; Harada H; Kohara M; Honma K; Nakatsuka SI; Morii E
Med Mol Morphol; 2021 Mar; 54(1):23-30. PubMed ID: 32488412
[TBL] [Abstract][Full Text] [Related]
3. Mammary analogue secretory carcinoma of parotid: Is preoperative cytological diagnosis possible?
Oza N; Sanghvi K; Shet T; Patil A; Menon S; Ramadwar M; Kane S
Diagn Cytopathol; 2016 Jun; 44(6):519-25. PubMed ID: 26945684
[TBL] [Abstract][Full Text] [Related]
4. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.
Bishop JA; Yonescu R; Batista D; Begum S; Eisele DW; Westra WH
Hum Pathol; 2013 Oct; 44(10):1982-8. PubMed ID: 23773480
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma.
Hung YP; Jo VY; Hornick JL
Histopathology; 2019 Jul; 75(1):54-62. PubMed ID: 30801752
[TBL] [Abstract][Full Text] [Related]
6. [Mammary analog secretory carcinoma of the parotid gland].
Guérin M; Diedhiou A; Nallet E; Duflo S; Laé M; Wassef M
Ann Pathol; 2014 Oct; 34(5):384-7. PubMed ID: 25439992
[TBL] [Abstract][Full Text] [Related]
7. Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland.
Bell D; Ferrarotto R; Liang L; Goepfert RP; Li J; Ning J; Broaddus R; Weber RS; El-Naggar AK
Virchows Arch; 2020 Feb; 476(2):295-305. PubMed ID: 31423558
[TBL] [Abstract][Full Text] [Related]
8. Cytopathological features of mammary analogue secretory carcinoma--review of literature.
Takeda M; Kasai T; Morita K; Takeuchi M; Nishikawa T; Yamashita A; Mikami S; Hosoi H; Ohbayashi C
Diagn Cytopathol; 2015 Feb; 43(2):131-7. PubMed ID: 24652816
[TBL] [Abstract][Full Text] [Related]
9. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.
Urano M; Nagao T; Miyabe S; Ishibashi K; Higuchi K; Kuroda M
Hum Pathol; 2015 Jan; 46(1):94-103. PubMed ID: 25456394
[TBL] [Abstract][Full Text] [Related]
10. Searching for mammary analogue [corrected] secretory carcinoma of salivary gland among its mimics.
Pinto A; Nosé V; Rojas C; Fan YS; Gomez-Fernandez C
Mod Pathol; 2014 Jan; 27(1):30-7. PubMed ID: 23807775
[TBL] [Abstract][Full Text] [Related]
11. Salivary Gland Secretory Carcinoma: Clinicopathologic and Genetic Characteristics of 215 Cases and Proposal for a Grading System.
Baněčková M; Thompson LDR; Hyrcza MD; Vaněček T; Agaimy A; Laco J; Simpson RHW; Di Palma S; Stevens TM; Brcic L; Etebarian A; Dimnik K; Majewska H; Stárek I; O'Regan E; Salviato T; Helliwell T; Horáková M; Biernat W; Onyuma T; Michal M; Leivo I; Skalova A
Am J Surg Pathol; 2023 Jun; 47(6):661-677. PubMed ID: 37070739
[TBL] [Abstract][Full Text] [Related]
12. Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, β-catenin, EGFR, and CCND1 genes.
Skálová A; Vanecek T; Majewska H; Laco J; Grossmann P; Simpson RH; Hauer L; Andrle P; Hosticka L; Branžovský J; Michal M
Am J Surg Pathol; 2014 Jan; 38(1):23-33. PubMed ID: 24145651
[TBL] [Abstract][Full Text] [Related]
13. Synchronous Parotid (Mammary Analog) Secretory Carcinoma and Acinic Cell Carcinoma: Report of a Case.
Mossinelli C; Pigni C; Sovardi F; Occhini A; Preda L; Benazzo M; Morbini P; Pagella F
Head Neck Pathol; 2019 Dec; 13(4):686-691. PubMed ID: 29876739
[TBL] [Abstract][Full Text] [Related]
14. Expanding the Molecular Spectrum of Secretory Carcinoma of Salivary Glands With a Novel VIM-RET Fusion.
Skálová A; Banečkova M; Thompson LDR; Ptáková N; Stevens TM; Brcic L; Hyrcza M; Michal M; Simpson RHW; Santana T; Michal M; Vaněček T; Leivo I
Am J Surg Pathol; 2020 Oct; 44(10):1295-1307. PubMed ID: 32675658
[TBL] [Abstract][Full Text] [Related]
15. High-grade transformation of acinic cell carcinoma: an inadequately treated entity?
Chintakuntlawar AV; Shon W; Erickson-Johnson M; Bilodeau E; Jenkins SM; Davidson JA; Keeney MG; Rivera M; Price DL; Moore EJ; Olsen KD; Kasperbauer JL; Foote RL; Price KA; García JJ
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 May; 121(5):542-549.e1. PubMed ID: 27017401
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics and outcome of 31 patients with ETV6-NTRK3 fusion gene confirmed (mammary analogue) secretory carcinoma of salivary glands.
Boon E; Valstar MH; van der Graaf WTA; Bloemena E; Willems SM; Meeuwis CA; Slootweg PJ; Smit LA; Merkx MAW; Takes RP; Kaanders JHAM; Groenen PJTA; Flucke UE; van Herpen CML
Oral Oncol; 2018 Jul; 82():29-33. PubMed ID: 29909898
[TBL] [Abstract][Full Text] [Related]
17. A challenging diagnosis of mammary analogue secretory carcinoma (MASC) on fine needle aspiration cytology and cell block: A cytopathologist's perspective.
Saraf P; Bharti JN; Malik A
Cytopathology; 2023 Jul; 34(4):377-380. PubMed ID: 36825352
[TBL] [Abstract][Full Text] [Related]
18. An Underappreciated Cytomorphological Feature of Secretory Carcinoma of Salivary Gland on Fine Needle Aspiration Biopsy: Case Report with Literature Review.
Hua Y; Leng B; Youens KE; Liu L
Head Neck Pathol; 2022 Jun; 16(2):567-572. PubMed ID: 34255277
[TBL] [Abstract][Full Text] [Related]
19. Mammary analog secretory carcinoma of salivary gland: cytologic diagnosis and differential diagnosis of an unreported entity.
Pisharodi L
Diagn Cytopathol; 2013 Mar; 41(3):239-41. PubMed ID: 22549921
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of phosphorylated signal transducer and activator of transcription 5 immunostaining in the diagnosis of mammary analogue secretory carcinoma of the salivary gland: A comparative study of salivary gland cancers.
Kawahara A; Taira T; Abe H; Takase Y; Kurita T; Sadashima E; Hattori S; Imamura I; Matsumoto S; Fujisaki H; Sueyoshi K; Akiba J; Kage M
Cancer Cytopathol; 2015 Oct; 123(10):603-11. PubMed ID: 26252941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
